|
|
mrna catabolic process
|
GO:0006402 |
56 |
0.994
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
48 |
0.987
|
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.980
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.974
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
14 |
0.974
|
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
23 |
0.971
|
|
|
|
cytoplasmic mrna processing body assembly
|
GO:0033962 |
10 |
0.969
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
81 |
0.954
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.899
|
|
|
|
histone mrna catabolic process
|
GO:0071044 |
10 |
0.898
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.835
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.825
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
25 |
0.791
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.744
|
|
|
|
positive regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060261 |
4 |
0.722
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.699
|
|
|
|
defense response to fungus
|
GO:0050832 |
4 |
0.699
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.657
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.650
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.643
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.642
|
|
|
|
ribonucleoprotein complex assembly
|
GO:0022618 |
78 |
0.604
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
1 |
0.533
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.504
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
25 |
0.416
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.400
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.397
|
|
|
|
histone mrna metabolic process
|
GO:0008334 |
13 |
0.372
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.344
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.292
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.282
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.249
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
23 |
0.247
|
|
|
|
avoidance of defenses of other organism involved in symbiotic interaction
|
GO:0051832 |
2 |
0.228
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.228
|
|
|
|
evasion or tolerance of host defenses
|
GO:0044415 |
2 |
0.204
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.201
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.191
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.182
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.182
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.168
|
|
|
|
zygotic specification of dorsal ventral axis
|
GO:0007352 |
2 |
0.163
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.161
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.144
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.142
|
|
|
|
gene silencing by rna
|
GO:0031047 |
26 |
0.138
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.133
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.130
|
|
|
|
heart valve formation
|
GO:0003188 |
2 |
0.126
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.122
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.115
|
|
|
|
negative regulation of smad protein complex assembly
|
GO:0010991 |
4 |
0.111
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.109
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.104
|
|
|
|
sebaceous gland development
|
GO:0048733 |
1 |
0.103
|
|
|
|
regulation of dna templated transcription initiation
|
GO:2000142 |
9 |
0.099
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.095
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.091
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.090
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.090
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.089
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
1 |
0.089
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
2 |
0.089
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.088
|
|
|
|
dna templated transcription elongation
|
GO:0006354 |
25 |
0.082
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.082
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.081
|
|
|
|
regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060260 |
8 |
0.081
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.081
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.080
|
|
|
|
deadenylation dependent decapping of nuclear transcribed mrna
|
GO:0000290 |
1 |
0.080
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.078
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.075
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.070
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.069
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.069
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.068
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.066
|
|
|
|
avoidance of host defenses
|
GO:0044413 |
2 |
0.066
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.065
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.064
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.062
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.062
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.062
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
23 |
0.062
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
14 |
0.060
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.060
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
3 |
0.060
|
|
|
|
response to host defenses
|
GO:0052200 |
2 |
0.058
|
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.056
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.055
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.053
|
|
|
|
evasion or tolerance of defenses of other organism involved in symbiotic interaction
|
GO:0051834 |
2 |
0.052
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.051
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.051
|
|
|
|
hard palate development
|
GO:0060022 |
1 |
0.050
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.048
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.048
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.048
|
|
|
|
positive regulation of transcription factor import into nucleus
|
GO:0042993 |
25 |
0.048
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
1 |
0.047
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.045
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.044
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.044
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.044
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.044
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
18 |
0.044
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.043
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.042
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.041
|
|
|
|
evasion or tolerance of host defenses by virus
|
GO:0019049 |
2 |
0.041
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.041
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
2 |
0.040
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.040
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.039
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.039
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.039
|
|
|
|
regulation of smad protein complex assembly
|
GO:0010990 |
4 |
0.039
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.039
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.039
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.038
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.038
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.038
|
|
|
|
response to defenses of other organism involved in symbiotic interaction
|
GO:0052173 |
2 |
0.038
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.038
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.037
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.037
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.037
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.037
|
|
|
|
system process
|
GO:0003008 |
349 |
0.036
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.036
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.036
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
2 |
0.036
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.036
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.035
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.035
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.035
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.035
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.034
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.034
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.034
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.034
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.034
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.033
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.033
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.033
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.033
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.033
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.033
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.032
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.032
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.032
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.032
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
2 |
0.032
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.031
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.031
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.031
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.031
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.031
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.031
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.030
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.030
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.030
|
|
|
|
pathway restricted smad protein phosphorylation
|
GO:0060389 |
38 |
0.030
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.030
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
2 |
0.030
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.029
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.029
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.029
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.029
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.029
|
|
|
|
negative regulation of pathway restricted smad protein phosphorylation
|
GO:0060394 |
11 |
0.029
|
|
|
|
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900224 |
1 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.028
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.028
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.028
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.028
|
|
|
|
otic vesicle development
|
GO:0071599 |
1 |
0.028
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.028
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.028
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.028
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.027
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.027
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.027
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.027
|
|
|
|
translation
|
GO:0006412 |
132 |
0.027
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.027
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.026
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.026
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.026
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.025
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.025
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.025
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.025
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.024
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.024
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.024
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.023
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.023
|
|
|
|
rna localization
|
GO:0006403 |
41 |
0.023
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.023
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.023
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.023
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.023
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.023
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.022
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.022
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
41 |
0.022
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.022
|
|
|
|
regulation of organelle assembly
|
GO:1902115 |
40 |
0.022
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.022
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.021
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.021
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.021
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.021
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.021
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.021
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.021
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.020
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.020
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.020
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.020
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.020
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.020
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.020
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.020
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.019
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.019
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.019
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.019
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.019
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.019
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.019
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.019
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.019
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
45 |
0.019
|
|
|
|
endocardium development
|
GO:0003157 |
2 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.019
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.019
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.019
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.019
|
|
|
|
regulation of pathway restricted smad protein phosphorylation
|
GO:0060393 |
34 |
0.019
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
11 |
0.018
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.018
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
28 |
0.018
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.018
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.018
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.018
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.018
|
|
|
|
transcription factor import into nucleus
|
GO:0042991 |
40 |
0.018
|
|
|
|
negative regulation of schwann cell proliferation
|
GO:0010626 |
1 |
0.018
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.018
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.018
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.018
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
1 |
0.018
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.018
|
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.018
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.017
|
|
|
|
regulation of nodal signaling pathway involved in determination of left right asymmetry
|
GO:1900145 |
1 |
0.017
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.017
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.017
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.017
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
1 |
0.017
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.017
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
18 |
0.017
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.017
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.017
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.017
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.017
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.017
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.017
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.017
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.017
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.017
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.017
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.017
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
50 |
0.017
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.016
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.016
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.016
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.016
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.016
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
59 |
0.016
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
4 |
0.016
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.016
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.016
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.016
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.016
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.016
|
|
|
|
spliceosomal snrnp assembly
|
GO:0000387 |
28 |
0.016
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
2 |
0.016
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.016
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.016
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.015
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.015
|
|
|
|
regulation of nodal signaling pathway
|
GO:1900107 |
1 |
0.015
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.015
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.015
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.015
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.015
|
|
|
|
regulation of cytoplasmic mrna processing body assembly
|
GO:0010603 |
5 |
0.015
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.015
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.015
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.015
|
|
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.015
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.015
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.015
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.015
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.015
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.015
|
|
|
|
modulation by virus of host morphology or physiology
|
GO:0019048 |
10 |
0.015
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.015
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.015
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
1 |
0.014
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.014
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.014
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.014
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.014
|
|
|
|
er associated ubiquitin dependent protein catabolic process
|
GO:0030433 |
31 |
0.014
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.014
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.014
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.014
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.014
|
|
|
|
dosage compensation
|
GO:0007549 |
3 |
0.014
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.014
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.014
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.014
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.014
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
1 |
0.013
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.013
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.013
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.013
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
8 |
0.013
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.013
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.013
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.013
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.013
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.013
|
|
|
|
protein complex localization
|
GO:0031503 |
31 |
0.013
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.013
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.013
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.013
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.013
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.013
|
|
|
|
pericardium development
|
GO:0060039 |
2 |
0.013
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
8 |
0.013
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.013
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.013
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.013
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.013
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.013
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.013
|
|
|
|
regulation of protein deubiquitination
|
GO:0090085 |
4 |
0.013
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.013
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.013
|
|
|
|
sexual reproduction
|
GO:0019953 |
37 |
0.013
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
2 |
0.013
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.013
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.013
|
|
|
|
growth
|
GO:0040007 |
202 |
0.013
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.012
|
|
|
|
convergent extension
|
GO:0060026 |
1 |
0.012
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.012
|
|
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.012
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.012
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.012
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.012
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.012
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
1 |
0.012
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.012
|
|
|
|
axis specification
|
GO:0009798 |
12 |
0.012
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.012
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.012
|
|
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.012
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.012
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.012
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.012
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.012
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.012
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.012
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.012
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.012
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.012
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.012
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.012
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.012
|
|
|
|
negative regulation of translation
|
GO:0017148 |
37 |
0.011
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.011
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.011
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.011
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
2 |
0.011
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.011
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.011
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
3 |
0.011
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.011
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.011
|
|
|
|
negative regulation of ubiquitin protein transferase activity
|
GO:0051444 |
8 |
0.011
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.011
|
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.011
|
|
|
|
head development
|
GO:0060322 |
108 |
0.011
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.011
|
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.011
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.011
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
12 |
0.011
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
4 |
0.011
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.011
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.011
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.011
|
|
|
|
regulation of ligase activity
|
GO:0051340 |
29 |
0.011
|
|
|
|
positive regulation of cell cell adhesion
|
GO:0022409 |
22 |
0.011
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.011
|
|
|
|
memory
|
GO:0007613 |
3 |
0.011
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.011
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.011
|
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.011
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.011
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.011
|
|
|
|
positive regulation of transcription during mitosis
|
GO:0045897 |
2 |
0.011
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.011
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.011
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.011
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
17 |
0.011
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.011
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.011
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.011
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.011
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.011
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.010
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.010
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.010
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.010
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.010
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.010
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.010
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.010
|
|
|
|
mitotic spindle elongation
|
GO:0000022 |
4 |
0.010
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
42 |
0.010
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.010
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.010
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.010
|
|
|
|
visual learning
|
GO:0008542 |
1 |
0.010
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.010
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.010
|
|
|
|
positive regulation of dna binding
|
GO:0043388 |
17 |
0.010
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
38 |
0.010
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.010
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.010
|
|